5 Analysts Have This to Say About Exact Sciences
Portfolio Pulse from Benzinga Insights
Exact Sciences (NASDAQ:EXAS) has received 5 analyst ratings in the last quarter, with 2 bullish and 3 somewhat bullish, and no indifferent, somewhat bearish, or bearish ratings. The average 12-month price target for EXAS is $86.6, with a high of $90.00 and a low of $80.00, representing an 8.84% decrease from the previous target of $95.00.
December 14, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Exact Sciences has a positive outlook from analysts with 5 favorable ratings and an average price target of $86.6, which is lower than the previous target of $95.
The overall positive ratings from analysts suggest a bullish sentiment towards EXAS, which could lead to a short-term increase in stock price. However, the decrease in the average price target may temper some of the potential upside.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100